A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
114 locations incl. Birmingham
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 12, 2026
Clinical Research Institute
Clinical research site in Minneapolis, Minnesota · 825 NICOLLET MALL STE 1135, MINNEAPOLIS, MN 55402-2700 · (612) 333-2200 · Website
Part of Clinical Research Institute
As of July 2026, 9 paid clinical trials are recruiting at Clinical Research Institute in Minneapolis, Minnesota. Active studies at this site cover conditions such as Migraine, Lichen Planopilaris and Chronic Spontaneous Urticaria (CSU). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Clinical Research Institute (9)
A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris
for Lichen Planopilaris
47 locations incl. Birmingham
Sponsor: Priovant Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT07532603·Phase 2, Phase 3·Recruiting·Listed Apr 2026
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for Chronic Spontaneous Urticaria (CSU)
128 locations incl. Birmingham
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT06868212·Phase 3·Recruiting·Listed Mar 2025
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
for Breast Cancer
23 locations incl. San Francisco
Sponsor: Olema Pharmaceuticals, Inc.
Sex: All·Age: 18+
Code: NCT07085767·Phase 3·Recruiting·Listed Jul 2025
A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
for Perennial Allergic Rhinitis (PAR)
27 locations incl. Huntington Beach
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06339008·Phase 3·Recruiting·Listed Apr 2024
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for Non-Small Cell Lung Cancer
89 locations incl. Chandler
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
for Acute Treatment of Migraine
13 locations incl. Little Rock
Sponsor: Pfizer
Sex: All·Age: 6 - 11
Code: NCT06995729·Phase 1·Recruiting·Listed May 2025
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
for Acute Hepatic Porphyria
11 locations incl. Birmingham
Sponsor: Alnylam Pharmaceuticals
Sex: All·Age: 12+
Code: NCT04883905·Recruiting·Listed May 2021
Lysosomal Acid Lipase (LAL) Deficiency Registry
for Lysosomal Acid Lipase Deficiency
20 locations incl. Phoenix
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All·Age: All ages
Code: NCT01633489·Recruiting·Listed Jul 2012
More research sites in Minneapolis
- University of Minnesota (308 trials)
- Abbott-Northwestern Hospital (85 trials)
- Hennepin County Medical Center (74 trials)
- University of Minnesota/Masonic Cancer Center (39 trials)
- Minneapolis Heart Institute Foundation (31 trials)
- Children's Hospitals and Clinics of Minnesota - Minneapolis (27 trials)
- Minneapolis VA Health Care System, Minneapolis, MN (27 trials)
- Health Partners Inc (26 trials)
- Masonic Cancer Center (15 trials)
- Minneapolis Heart Institute (14 trials)
Explore more
Paid clinical trials in Minneapolis, MN · Minnesota clinical trials